# Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer

> **NCT01888042** · PHASE2 · TERMINATED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 61 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01888042
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01888042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01888042, "Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01888042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*